McDermott Will & Emery advised Tissium on a Series D financing round. Tissium, a private medtech company specializing in the development of programmable biomorphic polymers for...
Tissium’s EUR50 Million Series D Fundraising
Luxempart Group’s Acquisition of a Minority Stake in Kestrel Vision
PwC advised Kestrel Vision. Ashurst advised Caravelle. McDermott Will & Emery advised Luxempart. Kestrel Vision, a global leader in glass control and inspection, has begun a...